Fidelity Investments’s Boundless Bio BOLD Stock Holding History

Fidelity Investments’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.96M	Buy	2,695,455 +11,433	+0.4%	+$13.4K	﹤0.01%	2499
2025 Q4	$3.22M	Sell	2,684,022 -414,049	-13%	-$516K	﹤0.01%	2431
2025 Q3	$3.81M	Sell	3,098,071 -27,032	-0.9%	-$31.2K	﹤0.01%	2326
2025 Q2	$3.16M	Sell	3,125,103 -32,669	-1%	-$43.4K	﹤0.01%	2327
2025 Q1	$4.77M	Sell	3,157,772 -187,234	-6%	-$388K	﹤0.01%	2167
2024 Q4	$9.7M	Buy	3,345,006 +6,922	+0.2%	+$20.2K	﹤0.01%	1949
2024 Q3	$11.6M	Sell	3,338,084 -96	-0%	-$348	﹤0.01%	1876
2024 Q2	$12.9M	Buy	3,338,180 +74,912	+2%	+$716K	﹤0.01%	1796
2024 Q1	$48.1M	Buy	+3,263,268	New	+$46.5M	﹤0.01%	1339

Other funds holding BOLD

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Fidelity Investments's BOLD Position: Q1 2026 in Review

Fidelity Investments increased its Boundless Bio (BOLD) stake by 0.43% in Q1 2026, buying an estimated $13.4K and bringing the position to 2,695,455 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Fidelity Investments first reported a position in BOLD in Q1 2024 and has held it in 9 quarters since. The position peaked at $48.1M in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

Fidelity Investments held 2,695,455 shares of Boundless Bio worth $2.96M as of Q1 2026.
Fidelity Investments bought 11,433 Boundless Bio shares in Q1 2026, an estimated $13.4K.
Boundless Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2499 holding.
Fidelity Investments first reported a position in Boundless Bio in Q1 2024 and has held it in 9 quarters since.
Fidelity Investments's Boundless Bio position peaked at $48.1M in Q1 2024.
36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.